What is the projected market valuation of the Allergy Diagnostic Market by 2035?

The Allergy Diagnostic Market is projected to reach approximately 6.849 USD Billion by 2035. Read More

What was the market valuation of the Allergy Diagnostic Market in 2024?

In 2024, the Allergy Diagnostic Market was valued at 4.53 USD Billion. Read More

What is the expected CAGR for the Allergy Diagnostic Market during the forecast period 2025 - 2035?

The expected CAGR for the Allergy Diagnostic Market during the forecast period 2025 - 2035 is 3.83%. Read More

Which segment is expected to show the highest growth in the Allergy Diagnostic Market?

The Food Allergens segment is anticipated to grow from 1.5 USD Billion in 2024 to 2.2 USD Billion by 2035. Read More

What are the key players in the Allergy Diagnostic Market?

Key players in the Allergy Diagnostic Market include Thermo Fisher Scientific, Roche Diagnostics, and Abbott Laboratories. Read More

How do In-Vitro Tests compare to Skin Prick Tests in market valuation?

In 2024, In-Vitro Tests were valued at 1.5 USD Billion, while Skin Prick Tests were valued at 1.2 USD Billion. Read More

What is the market valuation for the Home Care segment in 2024?

The Home Care segment was valued at 0.93 USD Billion in 2024. Read More

Which diagnostic method is projected to grow the most by 2035?

Immunoassays are projected to grow from 1.5 USD Billion in 2024 to 2.2 USD Billion by 2035. Read More

What is the expected market size for Environmental Allergens by 2035?

The Environmental Allergens segment is expected to reach approximately 2.3 USD Billion by 2035. Read More

How does the market for Drug Allergens compare to Insect Allergens in 2024?

In 2024, Drug Allergens were valued at 0.8 USD Billion, whereas Insect Allergens were valued at 0.73 USD Billion. Read More

Allergy Diagnostic Market

ID: MRFR/HC/40377-HCR

200 Pages

Rahul Gotadki

Last Updated: April 24, 2026

Allergy Diagnostic Market Research Report By Test Type (In-Vitro Tests, Skin Prick Tests, Intradermal Tests, Patch Tests), By Allergen Type (Food Allergens, Environmental Allergens, Drug Allergens, Insect Allergens), By End User (Hospitals, Clinics, Laboratories, Home Care), By Diagnostics Method (Immunoassays, Molecular Diagnostics, Enzyme-linked Immunosorbent Assay, Radioallergosorbent Test) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Allergy Diagnostic Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)3.83%

2024 Market Size$ 4.53 Billion

2025 Market Size$ 4.7 Billion

2035 Market Size$ 6.85 Billion

Key Players

Thermo Fisher Scientific

Roche Diagnostics

Abbott Laboratories

Siemens Healthineers

Danaher Corporation

Merck KGaA

Trends

Technological Advancements in Diagnostics
Increased Focus on Personalized Medicine
Rising Awareness and Education

Opportunities

Rising Incidence of Allergies
Regulatory Support and Standardization
Increased Focus on Personalized Medicine

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Test Type (USD Billion)
  1. 4.1.1 In-Vitro Tests
  2. 4.1.2 Skin Prick Tests
  3. 4.1.3 Intradermal Tests
  4. 4.1.4 Patch Tests
2. 4.2 Healthcare, BY Allergen Type (USD Billion)
  1. 4.2.1 Food Allergens
  2. 4.2.2 Environmental Allergens
  3. 4.2.3 Drug Allergens
  4. 4.2.4 Insect Allergens
3. 4.3 Healthcare, BY End User (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Clinics
  3. 4.3.3 Laboratories
  4. 4.3.4 Home Care
4. 4.4 Healthcare, BY Diagnostics Method (USD Billion)
  1. 4.4.1 Immunoassays
  2. 4.4.2 Molecular Diagnostics
  3. 4.4.3 Enzyme-linked Immunosorbent Assay
  4. 4.4.4 Radioallergosorbent Test
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Danaher Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Merck KGaA (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Quest Diagnostics (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Hoffmann-La Roche (CH)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bio-Rad Laboratories (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TEST TYPE
4. 6.4 US MARKET ANALYSIS BY ALLERGEN TYPE
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 US MARKET ANALYSIS BY DIAGNOSTICS METHOD
7. 6.7 CANADA MARKET ANALYSIS BY TEST TYPE
8. 6.8 CANADA MARKET ANALYSIS BY ALLERGEN TYPE
9. 6.9 CANADA MARKET ANALYSIS BY END USER
10. 6.10 CANADA MARKET ANALYSIS BY DIAGNOSTICS METHOD
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY TEST TYPE
13. 6.13 GERMANY MARKET ANALYSIS BY ALLERGEN TYPE
14. 6.14 GERMANY MARKET ANALYSIS BY END USER
15. 6.15 GERMANY MARKET ANALYSIS BY DIAGNOSTICS METHOD
16. 6.16 UK MARKET ANALYSIS BY TEST TYPE
17. 6.17 UK MARKET ANALYSIS BY ALLERGEN TYPE
18. 6.18 UK MARKET ANALYSIS BY END USER
19. 6.19 UK MARKET ANALYSIS BY DIAGNOSTICS METHOD
20. 6.20 FRANCE MARKET ANALYSIS BY TEST TYPE
21. 6.21 FRANCE MARKET ANALYSIS BY ALLERGEN TYPE
22. 6.22 FRANCE MARKET ANALYSIS BY END USER
23. 6.23 FRANCE MARKET ANALYSIS BY DIAGNOSTICS METHOD
24. 6.24 RUSSIA MARKET ANALYSIS BY TEST TYPE
25. 6.25 RUSSIA MARKET ANALYSIS BY ALLERGEN TYPE
26. 6.26 RUSSIA MARKET ANALYSIS BY END USER
27. 6.27 RUSSIA MARKET ANALYSIS BY DIAGNOSTICS METHOD
28. 6.28 ITALY MARKET ANALYSIS BY TEST TYPE
29. 6.29 ITALY MARKET ANALYSIS BY ALLERGEN TYPE
30. 6.30 ITALY MARKET ANALYSIS BY END USER
31. 6.31 ITALY MARKET ANALYSIS BY DIAGNOSTICS METHOD
32. 6.32 SPAIN MARKET ANALYSIS BY TEST TYPE
33. 6.33 SPAIN MARKET ANALYSIS BY ALLERGEN TYPE
34. 6.34 SPAIN MARKET ANALYSIS BY END USER
35. 6.35 SPAIN MARKET ANALYSIS BY DIAGNOSTICS METHOD
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY ALLERGEN TYPE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY DIAGNOSTICS METHOD
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY TEST TYPE
42. 6.42 CHINA MARKET ANALYSIS BY ALLERGEN TYPE
43. 6.43 CHINA MARKET ANALYSIS BY END USER
44. 6.44 CHINA MARKET ANALYSIS BY DIAGNOSTICS METHOD
45. 6.45 INDIA MARKET ANALYSIS BY TEST TYPE
46. 6.46 INDIA MARKET ANALYSIS BY ALLERGEN TYPE
47. 6.47 INDIA MARKET ANALYSIS BY END USER
48. 6.48 INDIA MARKET ANALYSIS BY DIAGNOSTICS METHOD
49. 6.49 JAPAN MARKET ANALYSIS BY TEST TYPE
50. 6.50 JAPAN MARKET ANALYSIS BY ALLERGEN TYPE
51. 6.51 JAPAN MARKET ANALYSIS BY END USER
52. 6.52 JAPAN MARKET ANALYSIS BY DIAGNOSTICS METHOD
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY ALLERGEN TYPE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSTICS METHOD
57. 6.57 MALAYSIA MARKET ANALYSIS BY TEST TYPE
58. 6.58 MALAYSIA MARKET ANALYSIS BY ALLERGEN TYPE
59. 6.59 MALAYSIA MARKET ANALYSIS BY END USER
60. 6.60 MALAYSIA MARKET ANALYSIS BY DIAGNOSTICS METHOD
61. 6.61 THAILAND MARKET ANALYSIS BY TEST TYPE
62. 6.62 THAILAND MARKET ANALYSIS BY ALLERGEN TYPE
63. 6.63 THAILAND MARKET ANALYSIS BY END USER
64. 6.64 THAILAND MARKET ANALYSIS BY DIAGNOSTICS METHOD
65. 6.65 INDONESIA MARKET ANALYSIS BY TEST TYPE
66. 6.66 INDONESIA MARKET ANALYSIS BY ALLERGEN TYPE
67. 6.67 INDONESIA MARKET ANALYSIS BY END USER
68. 6.68 INDONESIA MARKET ANALYSIS BY DIAGNOSTICS METHOD
69. 6.69 REST OF APAC MARKET ANALYSIS BY TEST TYPE
70. 6.70 REST OF APAC MARKET ANALYSIS BY ALLERGEN TYPE
71. 6.71 REST OF APAC MARKET ANALYSIS BY END USER
72. 6.72 REST OF APAC MARKET ANALYSIS BY DIAGNOSTICS METHOD
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY TEST TYPE
75. 6.75 BRAZIL MARKET ANALYSIS BY ALLERGEN TYPE
76. 6.76 BRAZIL MARKET ANALYSIS BY END USER
77. 6.77 BRAZIL MARKET ANALYSIS BY DIAGNOSTICS METHOD
78. 6.78 MEXICO MARKET ANALYSIS BY TEST TYPE
79. 6.79 MEXICO MARKET ANALYSIS BY ALLERGEN TYPE
80. 6.80 MEXICO MARKET ANALYSIS BY END USER
81. 6.81 MEXICO MARKET ANALYSIS BY DIAGNOSTICS METHOD
82. 6.82 ARGENTINA MARKET ANALYSIS BY TEST TYPE
83. 6.83 ARGENTINA MARKET ANALYSIS BY ALLERGEN TYPE
84. 6.84 ARGENTINA MARKET ANALYSIS BY END USER
85. 6.85 ARGENTINA MARKET ANALYSIS BY DIAGNOSTICS METHOD
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY ALLERGEN TYPE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSTICS METHOD
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY ALLERGEN TYPE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DIAGNOSTICS METHOD
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY ALLERGEN TYPE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DIAGNOSTICS METHOD
99. 6.99 REST OF MEA MARKET ANALYSIS BY TEST TYPE
100. 6.100 REST OF MEA MARKET ANALYSIS BY ALLERGEN TYPE
101. 6.101 REST OF MEA MARKET ANALYSIS BY END USER
102. 6.102 REST OF MEA MARKET ANALYSIS BY DIAGNOSTICS METHOD
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY ALLERGEN TYPE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY ALLERGEN TYPE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY DIAGNOSTICS METHOD, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY DIAGNOSTICS METHOD, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.2.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.3.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.4.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.5.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.6.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.7.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.8.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.9.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.10.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.11.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.12.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.13.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.14.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.15.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.16.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.17.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.18.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.19.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.20.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.21.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.22.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.23.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.24.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.25.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.26.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.27.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.28.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.29.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TEST TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY ALLERGEN TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.30.4 BY DIAGNOSTICS METHOD, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Allergy Diagnostic Market Segmentation

Allergy Diagnostic Market By Test Type (USD Billion, 2025-2035)

In-Vitro Tests
Skin Prick Tests
Intradermal Tests
Patch Tests

Allergy Diagnostic Market By Allergen Type (USD Billion, 2025-2035)

Food Allergens
Environmental Allergens
Drug Allergens
Insect Allergens

Allergy Diagnostic Market By End User (USD Billion, 2025-2035)

Hospitals
Clinics
Laboratories
Home Care

Allergy Diagnostic Market By Diagnostics Method (USD Billion, 2025-2035)

Immunoassays
Molecular Diagnostics
Enzyme-linked Immunosorbent Assay
Radioallergosorbent Test

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”